The purpose of the study is to investigate the tolerability of different injection/infusion volumes and speed compared to standard practise. The order in which the different volumes and injection speeds will be given to participants will be allocated by chance. Participants will be in this clinical study for about 1 week.
Informed consent obtained before any study-related activities. Study-related activities are any procedures that are carried out as part of the study, including activities to determine suitability for the study.
Healthy male or female participants as judged by the investigator.
Age 18-64 years (both inclusive) at the time of signing the informed consent.
Body Mass Index (BMI) greater than or equal to (>=) 18.5 and less than or equal to (<=) 30.0 kilograms per square metre (kg/m²) (both included).
Known or suspected hypersensitivity to study intervention(s) or related products.
Previous randomisation in this study.
Previous rescreening for this study.
Pregnant or breastfeeding female participants.